Association between copy number variations in parkin (<i>PRKN</i>) and schizophrenia and autism spectrum disorder: A case–control study

Tzuyao Lo(Nagoya University), Norio Ozaki(Nagoya University), Makoto Arai(Tokyo Metropolitan Institute of Medical Science), Hidekazu Kato(Nagoya University), Maeri Yamamoto(Nagoya University), Masanari Itokawa(Fujita Health University), Nakao Iwata(Fujita Health University), Yuka Yasuda(The University of Osaka), Michiko Fujimoto(National Center of Neurology and Psychiatry), Hirotaka Kosaka(University of Fukui), Ryo Kimura(DIC (Japan)), Tsutomu Takahashi(University of Toyama), Youta Torii(Nagoya University Hospital), Hidenori Yamasue(Hamamatsu University School of Medicine), Masahide Usami(National Center for Global Health and Medicine), Ryota Hashimoto(National Center of Neurology and Psychiatry), Toshiyuki Someya(Niigata University), Takashi Okada(Nagoya University), Itaru Kushima(Nagoya University), Yoshihiro Nawa(Nagoya University), Kazutaka Ohi(Tokyo Metropolitan Institute of Medical Science), Hiroki Kimura(Nagoya University), Yuichiro Watanabe(Niigata University), Michio Suzuki(Tokyo University of Agriculture), Branko Aleksić(Nagoya University), Jun Egawa(Niigata University), Masashi Ikeda(Fujita Health University), Toshio Munesue(Kanazawa University), Toshiya Inada(Nagoya University), Yasuko Funabiki(Kyoto University), Kiyoto Kasai(The University of Tokyo), Shusuke Numata(Tokushima University), Shigeru Yokoyama(Kanazawa University)
Neuropsychopharmacology Reports
November 1, 2023
Cited by 4


Related Papers